202
Participants
Start Date
April 30, 2004
Primary Completion Date
September 30, 2006
Study Completion Date
September 30, 2006
ZR-02-01 Fentanyl Transdermal Matrix Patch
Study patches were replaced every 72 hours and were to be applied on the upper chest or lateral aspect of the upper arms. The patch application sites were to be rotated so the patch was not applied to the same skin site for successive applications. Patients were supplied with Tegaderm if needed to keep the patches adhered during the 72 hour wear period.
Placebo Patch
Study patches were replaced every 72 hours and were to be applied on the upper chest or lateral aspect of the upper arms. The patch application sites were to be rotated so the patch was not applied to the same skin site for successive applications. Patients were supplied with Tegaderm if needed to keep the patches adhered during the 72 hour wear period
Beth Israel Medical Center, New York
Analgesic Development Ltd., New York
Radiant Research, Daytona Beach
Tampa Medical Group, Tampa
Ocala Rheumatology, Ocala
New Orleans Center for Clinical Research, New Orleans
Arizona Reserach Center, Phoenix
Redpoint Research, Phoenix
Boling Clinical Trials, Upland
Sharp Rees-Stealy Medical Group, San Diego
San Diego Arthritis Medical Clinic, San Diego
Pain Trials Center - Brigham & Women's Hospital, Boston
Phase III Clinical Trials, Fall River
ZARS Pharma Inc.
INDUSTRY